[
  {
    "ts": null,
    "headline": "Assessing DaVita (DVA) Valuation As Earnings Growth Optimism Builds Ahead Of Quarterly Results",
    "summary": "DaVita (DVA) is heading into its upcoming fourth quarter earnings release and conference call with investor attention firmly on expected earnings per share growth, as well as its current discount to the broader healthcare peer group. See our latest analysis for DaVita. DaVita’s recent share price performance has been mixed, with a 7 day share price return of 3.23% following a 90 day share price decline of 16.54%. The 1 year total shareholder return of 36.50% contrasts with weaker 5 year total...",
    "url": "https://finnhub.io/api/news?id=247b4cf4ee17d4cb0e6fe06040382f0389468c2793f56fe5ff9e5e4deb0dc900",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769360913,
      "headline": "Assessing DaVita (DVA) Valuation As Earnings Growth Optimism Builds Ahead Of Quarterly Results",
      "id": 138254797,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "DaVita (DVA) is heading into its upcoming fourth quarter earnings release and conference call with investor attention firmly on expected earnings per share growth, as well as its current discount to the broader healthcare peer group. See our latest analysis for DaVita. DaVita’s recent share price performance has been mixed, with a 7 day share price return of 3.23% following a 90 day share price decline of 16.54%. The 1 year total shareholder return of 36.50% contrasts with weaker 5 year total...",
      "url": "https://finnhub.io/api/news?id=247b4cf4ee17d4cb0e6fe06040382f0389468c2793f56fe5ff9e5e4deb0dc900"
    }
  }
]